Personalis to Announce Third Quarter 2024 Financial Results
2024年10月24日 - 5:01AM
ビジネスワイヤ(英語)
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics
for cancer, announced today that it will release its third quarter
2024 financial results on Wednesday, November 6, 2024. In
conjunction with the release, Personalis will host a conference
call and webcast that day at 2:00 p.m. Pacific Time / 5:00 p.m.
Eastern Time to discuss its financial results and recent
highlights.
Interested parties may access the call by dialing 877-451-6152
for domestic callers or 201-389-0879 for international callers. The
webinar of the call may be accessed by visiting the Events section
of the company's website at investors.personalis.com. A replay of
the webinar will be available shortly after the conclusion of the
call and will be archived on the company's website.
About Personalis, Inc.
At Personalis, we are transforming the active management of
cancer through breakthrough personalized testing. We aim to drive a
new paradigm for cancer management, guiding care from biopsy
through the life of the patient. Our highly sensitive assays
combine tumor-and-normal profiling with proprietary algorithms to
deliver advanced insights even as cancer evolves over time. Our
products are designed to detect minimal residual disease (MRD) and
recurrence at the earliest timepoints, enable selection of targeted
therapies based on ultra-comprehensive genomic profiling, and
enhance biomarker strategy for drug development. Personalis is
based in Fremont, California. To learn more, visit
www.personalis.com and connect with us on LinkedIn and X
(Twitter).
View source
version on businesswire.com: https://www.businesswire.com/news/home/20241023748852/en/
Investors: Caroline Corner investors@personalis.com
415-202-5678
Media: pr@personalis.com
Personalis (NASDAQ:PSNL)
過去 株価チャート
から 11 2024 まで 12 2024
Personalis (NASDAQ:PSNL)
過去 株価チャート
から 12 2023 まで 12 2024